Projects per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 5 Similar Profiles
Endocannabinoids
Medicine & Life Sciences
Cannabinoids
Medicine & Life Sciences
Dyskinesias
Medicine & Life Sciences
Schizophrenia
Medicine & Life Sciences
Cannabinoid Receptor Agonists
Medicine & Life Sciences
Parkinson Disease
Medicine & Life Sciences
Orthoptera
Medicine & Life Sciences
Cannabinoid Receptor CB1
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2004 2016
- 2 Finished
Endocannabinoid transmission in schizophrenia
6/1/11 → 3/31/16
Project: Research project › Research Project
Endocannabinoids
Schizophrenia
Cannabinoid Receptor CB1
Dronabinol
Pharmaceutical Preparations
Role of Endocannabinoids in Levodopa-Induced Dyskinesias
12/15/04 → 1/31/14
Project: Research project › Research Project
Endocannabinoids
Dyskinesias
Levodopa
Cannabinoid Receptor Agonists
Basal Ganglia
Research Output 1986 2018
Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia Susceptibility
Aguilar, D. D., Giuffrida, A. & Lodge, D. J., Apr 1 2018, In : International Journal of Neuropsychopharmacology. 21, 4, p. 393-403 11 p.Research output: Contribution to journal › Article
Cannabinoids
Dopaminergic Neurons
Rodentia
Schizophrenia
Psychotic Disorders
The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release
Seillier, A. & Giuffrida, A., Mar 1 2018, In : Neuropharmacology. 130, p. 1-9 9 p.Research output: Contribution to journal › Article
Endocannabinoids
Cannabinoids
Interpersonal Relations
Cannabinoid Receptor CB1
2-(2-(5-bromo-1H-indol-3-yl)ethyl)-3-(1-methylethoxyphenyl)-4-(3H)-quinazolinone
Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia
Seillier, A. & Giuffrida, A., Jul 12 2017, (Accepted/In press) In : Behavioural Pharmacology.Research output: Contribution to journal › Article
Phencyclidine
Schizophrenia
Anxiety
Diazepam
Cannabinoid Receptor Agonists
The Endocannabinoid System and Parkinson Disease
Giuffrida, A. & Martinez, A., May 16 2017, The Endocannabinoid System: Genetics, Biochemistry, Brain Disorders, and Therapy. Elsevier Inc., p. 63-81 19 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Endocannabinoids
Parkinson disease
Parkinson Disease
cannabinoids
Cannabinoids
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease
Mulas, G., Espa, E., Fenu, S., Spiga, S., Cossu, G., Pillai, E., Carboni, E., Simbula, G., Jadžić, D., Angius, F., Spolittu, S., Batetta, B., Lecca, D., Giuffrida, A. & Carta, A. R., Dec 1 2016, In : Experimental Neurology. 286, p. 83-92 10 p.Research output: Contribution to journal › Article
Oxidopamine
Dyskinesias
Parkinson Disease
Corpus Striatum
Tumor Necrosis Factor-alpha
Press/Media
Voelcker Fund Awards $1.45 Million for Young Faculty Research and $850,000 for Pipeline Science Education
William L Henrich, Linda M Mcmanus, Andrea Giuffrida, April L Risinger & Myron S Ignatius
6/26/18
1 item of media coverage
Press/Media: Press / Media
NIH awards more than $20M to UT Health San Antonio
William L Henrich & Andrea Giuffrida
5/31/18
1 item of media coverage
Press/Media: Press / Media
UT Health San Antonio Receives $24 Million NIH Research Boost
Kenneth M Hargreaves, Patricia L Dahia, Donald M Dougherty, Sara E Espinoza, William L Henrich, Linda M Mcmanus, Paula K Shireman, Robert A Clark, William P Clarke, Andrea Giuffrida & Joel Tsevat
5/31/18
1 item of media coverage
Press/Media: Press / Media
Expert Panel Recommends CBD Medication for Use in 2 Epilepsies
Linda D Leary, Andrea Giuffrida & Charles P France
4/19/18
1 item of media coverage
Press/Media: Press / Media
CSPC PHARMACEUTICAL : Licensing Agreements Target Spinal Cord Injury, Cancer
William L Henrich, Andrea Giuffrida & Jean X Jiang
6/24/17
1 item of media coverage
Press/Media: Press / Media